OMX30 1 604 0,2%  OMXH25 3 938 -0,2%  OMXC20 1 032 0,7%  Dow 22 273 -0,3%  Nas 5 862 -1,2%  EUR 9,5328 -0,1%  USD 8,0486 0,6%  Olja 58,5 2,8%  Guld 1 309 0,9% 

Indivior Aktie

<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Indivior

2016 2017e 2018e 2019e 2020e
Utdelning - - - - -
Direktavkastning (i %) - 3,25 3,37 3,79 -
PE-tal 10,55 11,12 19,94 15,22 9,74
Resultat/aktie 0,27 0,28 0,16 0,21 0,32
ytterligare nyheter

Analyser om Indivior PLC

ytterligare analyser

Indivior Peer Group

Indivior 3,29
1,2%
pagehit

Lägg till instrument

Vad tycker du?

Profil Indivior PLCtill bolagsprofilen

Indivior Plc is a pharmaceutical company which focuses on the treatment of addiction and closely related mental health disorders. It is engaged in the manufacture and distribution of products for the treatment of opioid dependence. The company's products include Suboxone Film, Suboxone Tablet and Subutex Tablet. It also sells Temgesic sublingual tablets and injections outside the U.S. for the treatment of moderate to severe pain and Buprenex injection in the U.S. for the relief of moderate to severe pain. The company also includes the treatments for the chronic relapsing conditions and co-morbidities of addiction. Indivior was founded on September 26, 2014 and is headquartered in Slough, United Kingdom.

Realtidskurs Indivior PLC

Bid 3,72 EUR Ask 3,80 EUR
Kurstid 10:34 Börsen STU

Till aktien Indivior

Ticker
ISIN GB00BRS65X63
Index FTSE 250

Indivior Nyckeltal

Börsvärde i SEK 24,52 Mrd
Free float % 99,75
Antal aktier mio. 721,46
Cashflow/aktie i lokal valuta 0,46
Bokvärde/aktie i lokal valuta -0,33
60 dagar vola 81,22
PBV -8,80